Frazier Management LLC Scholar Rock Holding Corp Transaction History

Frazier Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$11.89 - $24.68 $1.85 Million - $3.85 Million	-156,000 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$45.96 - $68.02 $114,900 - $170,050	2,500 Added 1.63%	156,000 $7.9 Million
Q4 2020 Feb 11, 2021	BUY	$13.72 - $51.57 $2.11 Million - $7.92 Million	153,500 New	153,500 $7.45 Million

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.35B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

Stay updated on Frazier Management LLC with notifications on news.